MEDI1191
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEDI1191, covering 2024-10-02 to 2024-10-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MEDI1191 in Sequential and Concurrent Combination With Durvalumab in Subjects With Advanced Solid Tumors [Phase 1]